• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ProgPerm:用于动态表示微生物组发现稳健性的渐进排列。

ProgPerm: Progressive permutation for a dynamic representation of the robustness of microbiome discoveries.

机构信息

Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Department of Statistics, University of Missouri, Columbia, MO, USA.

出版信息

BMC Bioinformatics. 2021 Mar 17;22(1):126. doi: 10.1186/s12859-021-04061-3.

DOI:10.1186/s12859-021-04061-3
PMID:33731016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7972227/
Abstract

BACKGROUND

Identification of features is a critical task in microbiome studies that is complicated by the fact that microbial data are high dimensional and heterogeneous. Masked by the complexity of the data, the problem of separating signals (differential features between groups) from noise (features that are not differential between groups) becomes challenging and troublesome. For instance, when performing differential abundance tests, multiple testing adjustments tend to be overconservative, as the probability of a type I error (false positive) increases dramatically with the large numbers of hypotheses. Moreover, the grouping effect of interest can be obscured by heterogeneity. These factors can incorrectly lead to the conclusion that there are no differences in the microbiome compositions.

RESULTS

We translate and represent the problem of identifying differential features, which are differential in two-group comparisons (e.g., treatment versus control), as a dynamic layout of separating the signal from its random background. More specifically, we progressively permute the grouping factor labels of the microbiome samples and perform multiple differential abundance tests in each scenario. We then compare the signal strength of the most differential features from the original data with their performance in permutations, and will observe a visually apparent decreasing trend if these features are true positives identified from the data. Simulations and applications on real data show that the proposed method creates a U-curve when plotting the number of significant features versus the proportion of mixing. The shape of the U-Curve can convey the strength of the overall association between the microbiome and the grouping factor. We also define a fragility index to measure the robustness of the discoveries. Finally, we recommend the identified features by comparing p-values in the observed data with p-values in the fully mixed data.

CONCLUSIONS

We have developed this into a user-friendly and efficient R-shiny tool with visualizations. By default, we use the Wilcoxon rank sum test to compute the p-values, since it is a robust nonparametric test. Our proposed method can also utilize p-values obtained from other testing methods, such as DESeq. This demonstrates the potential of the progressive permutation method to be extended to new settings.

摘要

背景

在微生物组研究中,特征的识别是一项关键任务,但由于微生物数据具有高度的维数和异质性,这一任务变得复杂。数据的复杂性掩盖了一个问题,即如何将信号(组间差异特征)与噪声(组间无差异特征)区分开来。例如,在进行差异丰度检验时,由于假阳性(I 型错误)的概率随着假设数量的增加而急剧增加,因此多重检验调整往往过于保守。此外,感兴趣的分组效应可能会被异质性所掩盖。这些因素可能会导致错误地得出微生物组组成没有差异的结论。

结果

我们将识别差异特征(在两组比较中差异显著的特征,例如治疗组与对照组)的问题转化为一种从随机背景中分离信号的动态布局。更具体地说,我们逐步置换微生物样本的分组因素标签,并在每种情况下进行多次差异丰度检验。然后,我们将原始数据中最具差异特征的信号强度与其在置换中的表现进行比较,如果这些特征是从数据中识别出的真正阳性特征,我们将观察到明显的下降趋势。模拟和实际数据应用表明,当绘制显著特征数量与混合比例的关系时,所提出的方法会产生 U 型曲线。U 型曲线的形状可以传达微生物组与分组因素之间总体关联的强度。我们还定义了一个脆弱性指数来衡量发现的稳健性。最后,我们通过将观察数据中的 p 值与完全混合数据中的 p 值进行比较,来推荐所识别的特征。

结论

我们已经开发了一个用户友好且高效的 R-shiny 工具,并进行了可视化处理。默认情况下,我们使用 Wilcoxon 秩和检验来计算 p 值,因为它是一种稳健的非参数检验。我们提出的方法也可以利用其他测试方法(如 DESeq)获得的 p 值。这表明渐进式置换方法具有扩展到新环境的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf14/7972227/16bd3f5ab435/12859_2021_4061_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf14/7972227/796cbe12e0fa/12859_2021_4061_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf14/7972227/9ce6a3af683d/12859_2021_4061_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf14/7972227/942b115a1166/12859_2021_4061_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf14/7972227/7afb9e62cb02/12859_2021_4061_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf14/7972227/8e903009fddf/12859_2021_4061_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf14/7972227/fbfe0db3b683/12859_2021_4061_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf14/7972227/de46bfa87fb4/12859_2021_4061_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf14/7972227/16bd3f5ab435/12859_2021_4061_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf14/7972227/796cbe12e0fa/12859_2021_4061_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf14/7972227/9ce6a3af683d/12859_2021_4061_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf14/7972227/942b115a1166/12859_2021_4061_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf14/7972227/7afb9e62cb02/12859_2021_4061_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf14/7972227/8e903009fddf/12859_2021_4061_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf14/7972227/fbfe0db3b683/12859_2021_4061_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf14/7972227/de46bfa87fb4/12859_2021_4061_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf14/7972227/16bd3f5ab435/12859_2021_4061_Fig8_HTML.jpg

相似文献

1
ProgPerm: Progressive permutation for a dynamic representation of the robustness of microbiome discoveries.ProgPerm:用于动态表示微生物组发现稳健性的渐进排列。
BMC Bioinformatics. 2021 Mar 17;22(1):126. doi: 10.1186/s12859-021-04061-3.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Rank normalization empowers a t-test for microbiome differential abundance analysis while controlling for false discoveries.秩归一化在控制假发现率的同时,增强了微生物组差异丰度分析的 t 检验。
Brief Bioinform. 2021 Sep 2;22(5). doi: 10.1093/bib/bbab059.
4
llperm: a permutation of regressor residuals test for microbiome data.llperm:一种针对微生物组数据的回归残差置换检验的置换检验。
BMC Bioinformatics. 2022 Dec 12;23(1):540. doi: 10.1186/s12859-022-05088-w.
5
A comprehensive evaluation of microbial differential abundance analysis methods: current status and potential solutions.微生物差异丰度分析方法的综合评估:现状与潜在解决方案。
Microbiome. 2022 Aug 19;10(1):130. doi: 10.1186/s40168-022-01320-0.
6
A realistic benchmark for differential abundance testing and confounder adjustment in human microbiome studies.用于人类微生物组研究中差异丰度检验和混杂因素调整的现实基准。
Genome Biol. 2024 Sep 25;25(1):247. doi: 10.1186/s13059-024-03390-9.
7
Powerful and robust non-parametric association testing for microbiome data via a zero-inflated quantile approach (ZINQ).基于零膨胀分位数方法(ZINQ)的微生物组数据强大而稳健的非参数关联检验。
Microbiome. 2021 Sep 2;9(1):181. doi: 10.1186/s40168-021-01129-3.
8
Cluster-level statistical inference in fMRI datasets: The unexpected behavior of random fields in high dimensions.功能磁共振成像数据集的簇水平统计推断:高维随机字段的意外行为
Magn Reson Imaging. 2018 Jun;49:101-115. doi: 10.1016/j.mri.2018.01.004. Epub 2018 Feb 3.
9
A maximum-type microbial differential abundance test with application to high-dimensional microbiome data analyses.一种基于最大似然的微生物差异丰度检验方法及其在高维微生物组数据分析中的应用。
Front Cell Infect Microbiol. 2022 Oct 28;12:988717. doi: 10.3389/fcimb.2022.988717. eCollection 2022.
10
Nonparametric methods for microarray data based on exchangeability and borrowed power.基于可交换性和借势的微阵列数据非参数方法。
J Biopharm Stat. 2005;15(5):783-97. doi: 10.1081/BIP-200067778.

引用本文的文献

1
Analysis of Microbiome Data.微生物组数据分析
Annu Rev Stat Appl. 2024 Apr;11(1):483-504. doi: 10.1146/annurev-statistics-040522-120734. Epub 2023 Oct 13.
2
Studying the microbiome of suppressive soils against vascular wilt, caused by Fusarium oxysporum in cape gooseberry (Physalis peruviana).研究由尖孢镰刀菌(Fusarium oxysporum)引起的醋栗番茄(Physalis peruviana)维管束萎蔫病抑制性土壤的微生物组。
Environ Microbiol Rep. 2023 Dec;15(6):757-768. doi: 10.1111/1758-2229.13195. Epub 2023 Sep 7.
3
Oral ecological environment modifications by hard-cheese: from pH to microbiome: a prospective cohort study based on 16S rRNA metabarcoding approach.

本文引用的文献

1
Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.肿瘤微生物组多样性和组成影响胰腺癌预后。
Cell. 2019 Aug 8;178(4):795-806.e12. doi: 10.1016/j.cell.2019.07.008.
2
PERFect: PERmutation Filtering test for microbiome data.PERFect:微生物组数据的排列过滤测试。
Biostatistics. 2019 Oct 1;20(4):615-631. doi: 10.1093/biostatistics/kxy020.
3
Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer.肠道微生物群介导的肥胖炎症:与胃肠道癌症的关联。
硬质奶酪对口腔生态环境的改变:从 pH 值到微生物组:基于 16S rRNA 代谢组学方法的前瞻性队列研究。
J Transl Med. 2022 Jul 9;20(1):312. doi: 10.1186/s12967-022-03506-4.
Nat Rev Gastroenterol Hepatol. 2018 Nov;15(11):671-682. doi: 10.1038/s41575-018-0025-6.
4
Best practices for analysing microbiomes.微生物组分析的最佳实践。
Nat Rev Microbiol. 2018 Jul;16(7):410-422. doi: 10.1038/s41579-018-0029-9.
5
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.肠道微生物组对癌症、免疫和癌症免疫治疗的影响。
Cancer Cell. 2018 Apr 9;33(4):570-580. doi: 10.1016/j.ccell.2018.03.015.
6
Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota.薜辛糖通过调节肠道微生物群改善 2 型糖尿病大鼠的症状。
Sci Rep. 2018 Feb 27;8(1):3685. doi: 10.1038/s41598-018-22094-2.
7
Gut microbiome populations are associated with structure-specific changes in white matter architecture.肠道微生物群与白质结构的特定变化有关。
Transl Psychiatry. 2018 Jan 10;8(1):6. doi: 10.1038/s41398-017-0022-5.
8
Discrete False-Discovery Rate Improves Identification of Differentially Abundant Microbes.离散错误发现率提高了差异丰富微生物的识别能力。
mSystems. 2017 Nov 21;2(6). doi: 10.1128/mSystems.00092-17. eCollection 2017 Nov-Dec.
9
Gut microbiome alterations in Alzheimer's disease.阿尔茨海默病中肠道微生物组的改变。
Sci Rep. 2017 Oct 19;7(1):13537. doi: 10.1038/s41598-017-13601-y.
10
The gut microbiome in atherosclerotic cardiovascular disease.动脉粥样硬化性心血管疾病中的肠道微生物群
Nat Commun. 2017 Oct 10;8(1):845. doi: 10.1038/s41467-017-00900-1.